Loading...
BTC Health Limited
BTC.AX•ASX
Healthcare
Biotechnology
A$0.07
A$0.00(0.00%)
BTC Health Limited (BTC.AX) Financial Performance & Income Statement Overview
Review BTC Health Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
23.38%
↑ 23.38%
Operating Income Growth
110.38%
↑ 110.38%
Net Income Growth
110.38%
↑ 110.38%
Operating Cash Flow Growth
6.65%
↑ 6.65%
Operating Margin
-6075.64%
↓ 6075.64%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
28328.19%
↑ 28328.19%
ROE
58.19%
↑ 58.19%
ROIC
-9.33%
↓ 9.33%
BTC Health Limited (BTC.AX) Income Statement & Financial Overview
Review BTC Health Limited's (BTC.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $7810.00 | $8550.00 | $7477.00 | $5783.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $7810.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $1.00 | $230.66 | $1326.38 | $45.61 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $603406.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $603406.00 | $0.00 | $0.00 | $0.00 |
| Total Costs & Expenses | $603406.00 | -$1.64M | $9.92M | $263788.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $0.00 |
| EBITDA | -$595596.00 | $1.65M | -$9.91M | -$258004.00 |
| EBITDA Ratio | -$76.26 | -$2.54 | -$1289.50 | -$6.62 |
| Operating Income | -$595596.00 | $1.65M | -$9.91M | -$258004.00 |
| Operating Income Ratio | -$76.26 | $193.09 | -$1325.38 | -$44.61 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | -$595596.00 | $1.65M | -$9.91M | -$258004.00 |
| Income Before Tax Ratio | -$76.26 | $0.00 | -$0.00 | -$44.61 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$595596.00 | $1.65M | -$9.91M | -$258004.00 |
| Net Income Ratio | -$76.26 | $36431.00 | $37695.00 | $48737.00 |
| EPS | -$0.002 | $0.005 | -$0.04 | $0.00 |
| Diluted EPS | -$0.002 | $0.005 | -$0.04 | $0.00 |
| Weighted Avg Shares Outstanding | $324.12M | $311.49M | $281.85M | $281.85M |
| Weighted Avg Shares Outstanding (Diluted) | $324.12M | $311.49M | $281.85M | $281.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan